Announce Date | 05/22/2025 |
EPS Normalized Actual | $-0.58 (Beat by $0.21) |
EPS GAAP Actual | $-0.58 (Beat by $0.21) |
Revenue Actual | $0.594336B |
Revenue Surprise | Beat by $594.336M |
Announce Date | 07/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.89 |
EPS GAAP Estimate | $0.89 |
Revenue Estimate | $0.7456B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jan 2030 | 0.19 | 103.32 | 0.18455 | 0.19479 | 1 |
Jan 2029 | 3.05 | 6.44 | 2.9408 | 3.14862 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Apr 2025) | -0.58 | -1.28 | 0.594336B | -5.78% | -85.96M |
FQ1 2025 (Jan 2025) | -1.93 | -2.784 | 0.759921B | -12.13% | -30.8M |
FQ4 2024 (Oct 2024) | 0.0757 | -1.0343 | 0.679824B | -2.1% | -97.7M |
FQ3 2024 (Jul 2024) | 0 | 0 | 0.633674B | -1.4% | 633.67M |
FQ2 2024 (Apr 2024) | 0.41 | 0.41 | 0.628703B | 9.4% | 628.7M |
FQ1 2024 (Jan 2024) | 0 | 0 | 0.852132B | 31.59% | 852.13M |
FQ4 2023 (Oct 2023) | 1.32 | 1.32 | 0.694115B | 3.65% | 694.12M |
FQ3 2023 (Jul 2023) | 1.38 | 1.38 | 0.642568B | 22.73% | 642.57M |
FQ4 Announce Date
07/30/2025 (Pre-Market)
Consensus EPS Estimates
0.89
Consensus Revenue Estimates
0.7456B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Jan 2027) | 0.12 | -- | 0.11208 | 0.12809 | 1 |
FQ4 2026 (Oct 2026) | 0.38 | -- | 0.3549 | 0.40562 | 1 |
FQ3 2026 (Jul 2026) | -0.02 | -- | -0.02134863 | -0.01867918 | 1 |
FQ2 2026 (Apr 2026) | -0.01 | -5700 | -0.01030985 | -0.00962865 | 1 |
FQ1 2026 (Jan 2026) | 0.73 | 364.38 | 0.69794 | 0.76215 | 0 |
FQ4 2025 (Oct 2025) | 1.08 | 92.99 | 1.04363 | 1.11258 | 2 |
FQ3 2025 (Jul 2025) | 0.89 | -- | 0.86003 | 0.91685 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Jan 2027) | 0.66B | -- | 0.63B | 0.69B | 2 |
FQ4 2026 (Oct 2026) | 0.59B | -- | 0.56B | 0.62B | 2 |
FQ3 2026 (Jul 2026) | 0.52B | -- | 0.49B | 0.54B | 2 |
FQ2 2026 (Apr 2026) | 0.45B | -31.75 | 0.44B | 0.46B | 2 |
FQ1 2026 (Jan 2026) | 0.88B | 13.6 | 0.85B | 0.91B | 1 |
FQ4 2025 (Oct 2025) | 0.8B | 14.5 | 0.77B | 0.81B | 1 |
FQ3 2025 (Jul 2025) | 0.75B | 15.01 | 0.73B | 0.76B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
3
EPS # of in-lines
2
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | 0.7 | -0.58 | -1.28 | 220.69% |
FQ1 2025 (Jan 2025) | 0.854 | -1.93 | -2.784 | 144.25% |
FQ4 2024 (Oct 2024) | 1.11 | 0.0757 | -1.0343 | -1366.31% |
FQ3 2024 (Jul 2024) | 0 | 0 | NAN% | |
FQ2 2024 (Apr 2024) | 0.41 | 0.41 | 100% | |
FQ1 2024 (Jan 2024) | 0 | 0 | NAN% | |
FQ4 2023 (Oct 2023) | 1.32 | 1.32 | 100% | |
FQ3 2023 (Jul 2023) | 1.38 | 1.38 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | $0.68B | $0.59B | $-85.96M | -14.46% |
FQ1 2025 (Jan 2025) | $0.79B | $0.76B | $-30.8M | -4.05% |
FQ4 2024 (Oct 2024) | $0.78B | $0.68B | $-97.7M | -14.37% |
FQ3 2024 (Jul 2024) | $0B | $0.63B | $633.67M | 100% |
FQ2 2024 (Apr 2024) | $0B | $0.63B | $628.7M | 100% |
FQ1 2024 (Jan 2024) | $0B | $0.85B | $852.13M | 100% |
FQ4 2023 (Oct 2023) | $0B | $0.69B | $694.12M | 100% |
FQ3 2023 (Jul 2023) | $0B | $0.64B | $642.57M | 100% |